Journal of Clinical Hypertension – “First‐line treatment of essential hypertension: A real‐world analysis across four antihypertensive treatment classes”

Apr 13, 2019 | Published Research

This study was written by Manfred Stapff, MD, PhD, Chief Medical Officer at TriNetX, and Sarah Hilderbrand, MSc and published in the Journal of Clinical Hypertension describing how electronic medical records can be used to analyze and compare actual treatment...

World Journal of Diabetes – “Using real world data to assess cardiovascular outcomes of two antidiabetic treatment classes”

Dec 15, 2018 | Published Research

This study published in the World Journal of Diabetes evaluates the effect on cardiovascular outcomes of sodium-glucose co-transporter-2 (SGLT2) inhibitors in a real world setting by analyzing electronic medical records.Manfred Paul Stapff, CMO, TriNetX Inc.,...

ISPOR Europe 2018 – Parkinson’s Disease Study

Nov 12, 2018 | Published Research

This scientific poster investigates the risk of Parkinson’s Disease (PD) in patients taking adrenergic drug treatments. Download the poster...

ISPOR Europe 2018 – Suicidality Study

Nov 12, 2018 | Published Research

This scientific poster is comparing the risk of suicidality in adult versus youth patients treated with serotonin reuptake inhibitors—A real-world evidence-based approach. Download the poster...

ISPOR Europe 2018 – Chronic Kidney Disease Study

Nov 12, 2018 | Published Research

This scientific poster investigates the risk of stroke or systemic embolism in chronic kidney disease patients with atrial fibrillation. Download the poster...

ISPOR Europe 2018 – Breast Cancer Study

Nov 12, 2018 | Published Research

This scientific poster explores real-world evidence of metastatic breast cancer treatment: a comparison of adverse effects between palbociclib treatment and endocrine therapy. Download the poster...